Clinical Trial Update: Prospera Test Evaluation in Cardiac Transplant (ProTECT)

View source ↗

Summary

The document provides a status update on the Prospera test evaluation in heart transplant rejection (ProTECT), indicating the trial is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection

Drugs mentioned

• Prospera (donor-derived cell-free DNA assay)

Snippet

Sponsor: Natera, Inc. | Conditions: Heart Transplant Rejection | Status: ACTIVE_NOT_RECRUITING